Status:
COMPLETED
Locally Administered Clodronate in the Prevention of Aseptic Implant Loosening
Lead Sponsor:
University of Oulu
Conditions:
Hip Arthrosis
Eligibility:
All Genders
Up to 73 years
Phase:
EARLY_PHASE1
Brief Summary
Periprosthetic bone-loss after total hip arthroplasty (THA), detected as an early migration of the prosthesis, may predict later loosening. The investigators hypothesized that by reducing bone resorpt...
Eligibility Criteria
Inclusion
- hip arthrosis and
- a primary THA was planned
Exclusion
- renal insufficiency
- hypercalcemia
- malignant tumors
- contemporaneously treatment with another bisphosphonate or aminoglycoside
Key Trial Info
Start Date :
March 26 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2014
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03803839
Start Date
March 26 2004
End Date
March 12 2014
Last Update
January 18 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.